Subscribe to our RSS feeds RSS | Login | Register  
 

 FDA Articles

Merck agrees to pre-approval of TV ads in Vioxx settlement

Matthew Arnold May 22, 2008

Merck has agreed to submit all TV ads to the FDA before running them and to adhere to agency recommendations on them as part of a Vioxx-related settlement.
 

FDA warns Shire on Fosrenol marketing materials

Stephen McGuire May 12, 2008

Shire received a warning letter from the FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) asking the drugmaker to halt distribution of specific professional marketing materials for its end stage renal disease treatment Fosrenol (lanthanum carbonate).
 

Panel against expanded Fentora approval

Stephen McGuire May 07, 2008

An FDA advisory panel ruled against expanded use of Cephalon's powerful pain reliever Fentora as a treatment for non-cancer patients.
 

Wyeth, Elan halt study of Alzheimer's vaccine

Stephen McGuire April 18, 2008

Wyeth and Elan have suspended a clinical study of their jointly developed Alzheimer's vaccine ACC-001 after a patient receiving the treatment was hospitalized for nearly two weeks with skin ulcers.
 

Are FDA deadlines behind marketplace safety issues?

Stephen McGuire March 27, 2008

FDA deadlines for new drug approvals may lead to safety issues with medicines once they make it to market, a New England Journal of Medicine study indicates.
 

FDA looking at possible Singulair suicidality connection

Matthew Arnold March 27, 2008

The FDA issued an early communication advising that it is investigating a possible risk of suicidality with Merck's allergy and asthma drug Singulair.
 

Gardasil sBLA given priority review

Stephen McGuire March 19, 2008

Merck said today that the FDA has granted priority review status to the company's supplemental Biologics License Application (sBLA) for Gardasil (human papillomavirus quadrivalent) for use in women aged 27 through 45.
 

Product news

March 18, 2008

Hawthorn Pharmaceuticals announced the FDA approval of the company's Granisol (granisetron HCl) oral solution. Granisol is an oral solution for the prevention of nausea and vomiting associated with cancer therapy.
 

Woodcock to return to CDER director post

Stephen McGuire March 11, 2008

FDA deputy commissioner Janet Woodcock will return to the role of permanent director of the Center for Drug Evaluation and Research following a "national search" to fill the slot.
 

FDA's off-label guidance harsh, but better than nothing, say legal experts

Matthew Arnold February 28, 2008

Sales reps could be effectively barred from circulating journal article reprints discussing off-label uses under FDA's draft guidance on "good reprint practices," and the agency considers the policy to be effective already, even in its draft form.